Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Challenges associated with developing a standardized technique for MRD detection in myeloma

Noemí Puig, MD, PhD, University Hospital Salamanca, Salamanca, Spain, comments on the challenges associated with developing a standardized technique for detecting measurable residual disease (MRD)-status in patients with myeloma. These include reproducibility, ease of use and interpretation, and cost. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.